Trial intelligence / Profile preview

Pyronaridine-artesunate for Uncomplicated Falciparum Malaria in Western Cambodia

NCT02389439Phase 2Completed

Sponsor
University of Oxford
Start
Mar 2015
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of artesunate + pyronaridine in Malaria, sponsored by University of Oxford. Started Mar 2015; status: completed.

02

Drugs

artesunate + pyronaridine
03

Conditions

Malaria

Beyond the preview

Go deeper on NCT02389439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02389439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call